SCHEMBL13724869

SCHEMBL13724869

Cc1ccc(-n2c3ccccc3c3cc(N(c4ccc(-c5ccc(N(c6cccc(-c7ccccc7)c6)c6ccc7c(c6)c6ccccc6n7-c6ccc(C)cc6)c6ccccc56)cc4)c4cccc(-c5ccccc5)c4)ccc32)cc1

nearest known ligand 0.35

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ TSPO P30536 2/20 0.35
▸ AKR1C4 P17516 1/20 0.35
▸ AKR1C3 P42330 1/20 0.35
▸ AKR1C2 P52895 1/20 0.35
▸ AKR1C1 Q04828 1/20 0.35
▸ L3MBTL1 Q9Y468 2/20 0.33
▸ KDM4E B2RXH2 1/20 0.33
▸ ATM Q13315 1/20 0.33
▸ APP P05067 1/20 0.32
▸ RXRA P19793 1/20 0.31
▸ RXRB P28702 1/20 0.31
▸ HDAC4 P56524 1/20 0.31
▸ PTGER4 P35408 1/20 0.30
▸ RAC2 P15153 1/20 0.30
▸ RAC3 P60763 1/20 0.30
▸ CDC42 P60953 1/20 0.30
▸ RAC1 P63000 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13486031 0.98 L3MBTL1 (0.36) TSPOAKR1C4AKR1C3AKR1C2AKR1C1
SCHEMBL13725019 0.96 TSPO (0.35) TSPOAKR1C4AKR1C3AKR1C2AKR1C1
SCHEMBL13724777 0.96 AKR1C4 (0.36) TSPOAKR1C4AKR1C3AKR1C2AKR1C1
SCHEMBL13485880 0.95 L3MBTL1 (0.38) TSPOAKR1C4AKR1C3AKR1C2AKR1C1
SCHEMBL13725685 0.95 L3MBTL1 (0.37) TSPOAKR1C4AKR1C3AKR1C2AKR1C1
SCHEMBL13803718 0.94 TSPO (0.39) TSPOAKR1C4AKR1C3AKR1C2AKR1C1
SCHEMBL13486035 0.94 L3MBTL1 (0.39) TSPOAKR1C4AKR1C3AKR1C2AKR1C1
SCHEMBL13485897 0.94 L3MBTL1 (0.39) TSPOAKR1C4AKR1C3AKR1C2AKR1C1
SCHEMBL13803715 0.94 TSPO (0.39) TSPOAKR1C4AKR1C3AKR1C2AKR1C1
SCHEMBL13724831 0.93 AKR1C4 (0.36) TSPOAKR1C4AKR1C3AKR1C2AKR1C1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8394511-B2 Compound for forming organic film, and organic light emitting device and flat panel display device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2013-03-12 — — US disclosed
US-8394511-B2 Compound for forming organic film, and organic light emitting device and flat panel display device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2013-03-12 — — US disclosed
US-20090200928-A1 COMPOUND FOR FORMING ORGANIC FILM, AND ORGANIC LIGHT EMITTING DEVICE AND FLAT PANEL DISPLAY DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2009-08-13 — — US disclosed
US-20090200928-A1 COMPOUND FOR FORMING ORGANIC FILM, AND ORGANIC LIGHT EMITTING DEVICE AND FLAT PANEL DISPLAY DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2009-08-13 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090200928-A1 COMPOUND FOR FORMING ORGANIC FILM, AND ORGANIC LIGHT EMITTING DEVICE AND FLAT PANEL DISPLAY DEVICE INCLUDING THE SAME SLCO4C1, PORCN, SLC7A5 TSPO 232/4885AKR1C4 3664/4885AKR1C3 4110/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback